Insider · CIK 0001352546
James E Flynn
Files at: NUVL, PBLS, SWAV, XERS, ACRS, ARVN, CNST, AERI and 32 more. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 DUForm 4 → | Jul 17, 3:27 pm EDT | Nuvalent, Inc.NUVL | 17,262,186 | $124.00 | $2,140,511,064 | 0 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 6:35 pm EDT | Nuvalent, Inc.NUVL | 3,444 | — | — | 3,444 | — | |
| Jun 11, 2026 CForm 4 → | Jun 11, 8:07 pm EDT | Parabilis Medicines, Inc.PBLS | 1,880,704 | — | — | 940,352 | — | |
| Mar 11, 2019 PForm 4 → | Mar 11, 2:16 pm EDT | ShockWave Medical, Inc.SWAV | 30,000 | $17.00 | $510,000 | 10,000 | — | plan? |
| Mar 11, 2019 CForm 4 → | Mar 11, 2:16 pm EDT | ShockWave Medical, Inc.SWAV | 312,146 | — | — | 156,073 | — | plan? |
| Feb 8, 2019 SForm 4 → | Feb 12, 5:55 pm EST | XERIS PHARMACEUTICALS INCXERS | 7,241 | $15.09 | $109,251 | 856,470 | −0.84% | plan? |
| Feb 5, 2019 SForm 4 → | Feb 7, 8:13 pm EST | XERIS PHARMACEUTICALS INCXERS | 14,807 | $15.02 | $222,443 | 863,711 | −1.69% | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 5:38 pm EST | XERIS PHARMACEUTICALS INCXERS | 7,038 | $15.12 | $106,448 | 878,518 | −0.79% | plan? |
| Jan 23, 2019 SForm 4 → | Jan 25, 6:24 pm EST | XERIS PHARMACEUTICALS INCXERS | 114,444 | $15.43 | $1,766,193 | 885,556 | −11.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 1, 1:47 pm EDT | ARVINAS INC.ARVN | 312,500 | $16.00 | $5,000,000 | 411,244 | +316% | plan? |
| Oct 1, 2018 CForm 4 → | Oct 1, 1:47 pm EDT | ARVINAS INC.ARVN | 921,234 | — | — | 307,078 | — | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 1:00 pm EDT | CONSTELLATION PHARMACEUTICALS INCCNST | 200,000 | $15.00 | $3,000,000 | 835,843 | +31.5% | plan? |
| Jul 23, 2018 CForm 4 → | Jul 23, 1:00 pm EDT | CONSTELLATION PHARMACEUTICALS INCCNST | 635,843 | — | — | 635,843 | — | plan? |
| Jun 25, 2018 PForm 4 → | Jun 27, 4:58 pm EDT | XERIS PHARMACEUTICALS INCXERS | 750,000 | $15.00 | $11,250,000 | 1,498,666 | +100% | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:58 pm EDT | XERIS PHARMACEUTICALS INCXERS | 1,748,666 | — | — | 874,333 | — | plan? |
| Jun 25, 2018 SForm 4 → | Jun 25, 5:59 pm EDT | AVADEL PHARMACEUTICALS PLCAVDL | 114,034 | $5.99 | $683,315 | 952,265 | −10.7% | plan? |
| May 29, 2018 PForm 4 → | May 31, 4:19 pm EDT | Kiniksa Pharmaceuticals, Ltd.KNSA | 843,352 | $18.97 | $15,996,834 | 843,352 | — | plan? |
| May 29, 2018 CForm 4 → | May 31, 4:19 pm EDT | Kiniksa Pharmaceuticals, Ltd.KNSA | 383,538 | — | — | 383,538 | — | plan? |
| May 9, 2018 SForm 4 → | May 10, 4:51 pm EDT | Mallinckrodt plcMNK | 312,928 | $13.39 | $4,189,818 | 8,308,455 | −3.63% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 4, 8:56 pm EDT | Homology Medicines, Inc.FIXX | 1,250,000 | $16.00 | $20,000,000 | 625,000 | — | plan? |
| Apr 2, 2018 CForm 4 → | Apr 4, 8:56 pm EDT | Homology Medicines, Inc.FIXX | 3,977,035 | — | — | 1,988,517 | — | plan? |
| Apr 2, 2018 JForm 4 → | Apr 4, 4:09 pm EDT | DFB Healthcare Acquisitions Corp.DFBH | 925,761 | — | — | 26,087 | — | plan? |
| Mar 6, 2018 SForm 4/A → | Mar 21, 4:12 pm EDT | CATALYST BIOSCIENCES, INC.CBIO | 71,778 | $30.53 | $2,191,045 | 305,965 | −19.0% | plan? |
| Mar 6, 2018 SForm 4 → | Mar 8, 5:18 pm EST | CATALYST BIOSCIENCES, INC.CBIO | 71,778 | $30.53 | $2,191,045 | 1,113,222 | −6.06% | plan? amended |
| Feb 21, 2018 PForm 4 → | Feb 23, 4:00 pm EST | DFB Healthcare Acquisitions Corp.DFBH | 2,500,000 | — | — | 2,500,000 | — | plan? |
| Nov 30, 2017 SForm 4 → | Dec 4, 5:17 pm EST | PROTEON THERAPEUTICS INCPRTO | 110,557 | $1.75 | $193,475 | 0 | −100% | plan? |
| Nov 30, 2017 PForm 4 → | Dec 4, 5:17 pm EST | PROTEON THERAPEUTICS INCPRTO | 110,557 | $1.75 | $193,475 | 197,424 | +127% | plan? |
| Oct 10, 2017 PForm 4 → | Oct 10, 9:40 am EDT | RHYTHM PHARMACEUTICALS, INC.RYTM | 355,000 | $17.00 | $6,035,000 | 468,505 | +313% | plan? |
| Oct 10, 2017 CForm 4 → | Oct 10, 9:40 am EDT | RHYTHM PHARMACEUTICALS, INC.RYTM | 582,010 | — | — | 291,005 | — | plan? |
| Jun 12, 2017 SForm 4 → | Jun 14, 8:13 pm EDT | Recro Pharma, Inc.REPH | 110,447 | $6.39 | $706,226 | 1,176,685 | −8.58% | plan? |
| Jun 7, 2017 SForm 4 → | Jun 9, 4:07 pm EDT | Recro Pharma, Inc.REPH | 62,868 | $7.06 | $444,010 | 1,287,132 | −4.66% | plan? |
| Apr 26, 2017 SForm 4 → | Apr 27, 7:00 pm EDT | eHealth, Inc.EHTH | 426,954 | $11.66 | $4,978,115 | 877,606 | −32.7% | plan? |
| Apr 13, 2017 SForm 4 → | Apr 17, 5:37 pm EDT | eHealth, Inc.EHTH | 150,000 | $11.00 | $1,650,000 | 975,375 | −13.3% | plan? |
| Apr 7, 2017 SForm 4 → | Apr 11, 5:56 pm EDT | eHealth, Inc.EHTH | 232,101 | $11.38 | $2,641,691 | 1,009,724 | −18.7% | plan? |
| Jan 24, 2017 SForm 4 → | Jan 26, 5:13 pm EST | CAS MEDICAL SYSTEMS INCCASM | 636,238 | $1.46 | $931,230 | 2,358,636 | −21.2% | plan? |
| Jan 19, 2017 SForm 4 → | Jan 23, 6:58 pm EST | CAS MEDICAL SYSTEMS INCCASM | 205,126 | $1.53 | $313,352 | 2,994,874 | −6.41% | plan? |
| Dec 12, 2016 SForm 4 → | Dec 14, 12:48 pm EST | Invuity, Inc.IVTY | 184,796 | $6.22 | $1,148,909 | 1,690,498 | −9.85% | plan? |
| Sep 22, 2016 SForm 4 → | Sep 26, 5:29 pm EDT | Vanda Pharmaceuticals Inc.VNDA | 1,120,461 | $16.56 | $18,559,971 | 693,171 | −61.8% | plan? |
| Sep 15, 2016 SForm 4 → | Sep 19, 6:42 pm EDT | Vanda Pharmaceuticals Inc.VNDA | 547,886 | $15.66 | $8,582,621 | 919,718 | −37.3% | plan? |
| Jul 25, 2016 PForm 4 → | Jul 25, 12:19 pm EDT | Audentes Therapeutics, Inc.BOLD | 400,000 | $15.00 | $6,000,000 | 514,424 | +350% | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 12:19 pm EDT | Audentes Therapeutics, Inc.BOLD | 1,003,654 | — | — | 367,828 | — | plan? |
| Jul 21, 2016 SForm 4 → | Jul 21, 4:26 pm EDT | AxoGen, Inc.AXGN | 102,136 | $6.70 | $684,311 | 3,000,000 | −3.29% | plan? |
| Jul 20, 2016 SForm 4 → | Aug 1, 7:14 pm EDT | ZAFGEN, INC.ZFGN | 1,341,499 | $3.31 | $4,442,776 | 1,151,802 | −53.8% | plan? late |
| Jul 14, 2016 SForm 4 → | Jul 18, 6:20 pm EDT | AxoGen, Inc.AXGN | 279,303 | $7.53 | $2,104,171 | 3,102,136 | −8.26% | plan? |
| Jul 6, 2016 PForm 4 → | Jul 6, 11:54 am EDT | Syros Pharmaceuticals, Inc.SYRS | 400,000 | $12.50 | $5,000,000 | 628,566 | +175% | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 11:54 am EDT | Syros Pharmaceuticals, Inc.SYRS | 1,695,220 | — | — | 508,566 | — | plan? |
| Jun 20, 2016 SForm 4 → | Jun 22, 4:32 pm EDT | eHealth, Inc.EHTH | 204,854 | $14.21 | $2,911,063 | 718,594 | −22.2% | plan? |
| Jun 14, 2016 SForm 4 → | Jun 16, 5:37 pm EDT | eHealth, Inc.EHTH | 43,300 | $13.88 | $601,169 | 923,448 | −4.48% | plan? |
| Jun 6, 2016 SForm 4 → | Jun 8, 5:17 pm EDT | eHealth, Inc.EHTH | 63,736 | $13.92 | $887,049 | 966,748 | −6.19% | plan? |
| May 31, 2016 SForm 4 → | Jun 2, 5:17 pm EDT | eHealth, Inc.EHTH | 99,508 | $13.85 | $1,378,435 | 1,030,484 | −8.81% | plan? |
| May 25, 2016 SForm 4 → | May 27, 5:18 pm EDT | eHealth, Inc.EHTH | 212,581 | $14.13 | $3,002,906 | 1,129,992 | −15.8% | plan? |
| Feb 19, 2016 PForm 4 → | Feb 23, 4:37 pm EST | XENOPORT INCXNPT | 20,973 | $3.99 | $83,647 | 2,746,650 | +0.77% | plan? |
| Feb 17, 2016 CForm 4 → | Feb 19, 12:38 pm EST | AveXis, Inc.AVXS | 1,486,383 | — | — | 249,909 | — | plan? |
| Feb 12, 2016 PForm 4 → | Feb 17, 2:02 pm EST | ZAFGEN, INC.ZFGN | 64,545 | $6.25 | $403,187 | 2,053,232 | +3.25% | plan? |
| Feb 11, 2016 PForm 4 → | Feb 16, 7:43 pm EST | XENOPORT INCXNPT | 4,883,761 | $3.87 | $18,917,621 | 2,734,905 | — | plan? |
| Feb 9, 2016 PForm 4 → | Feb 11, 8:21 pm EST | ZAFGEN, INC.ZFGN | 267,493 | $6.02 | $1,609,668 | 2,039,360 | +15.1% | plan? |
| Feb 8, 2016 PForm 4 → | Feb 8, 3:26 pm EST | Editas Medicine, Inc.EDIT | 100,000 | $16.00 | $1,600,000 | 954,700 | +11.7% | plan? |
| Feb 8, 2016 CForm 4 → | Feb 8, 3:26 pm EST | Editas Medicine, Inc.EDIT | 1,709,400 | — | — | 854,700 | — | plan? |
| Jan 20, 2016 PForm 4 → | Jan 22, 4:16 pm EST | XENOPORT INCXNPT | 346,417 | $4.09 | $1,418,404 | 6,667,391 | +5.48% | plan? |
| Dec 16, 2015 PForm 4 → | Dec 18, 7:43 pm EST | Vanda Pharmaceuticals Inc.VNDA | 11,170 | $8.97 | $100,156 | 1,103,617 | +1.02% | plan? |
| Dec 15, 2015 SForm 4 → | Dec 17, 7:00 pm EST | STREAMLINE HEALTH SOLUTIONS INC.STRM | 397,259 | $1.23 | $488,285 | 1,875,500 | −17.5% | plan? |
| Dec 10, 2015 PForm 4/A → | Dec 18, 7:40 pm EST | Vanda Pharmaceuticals Inc.VNDA | 425,982 | $8.60 | $3,665,308 | 1,100,378 | +63.2% | plan? |
| Dec 9, 2015 PForm 4 → | Dec 11, 6:06 pm EST | Vanda Pharmaceuticals Inc.VNDA | 1,201,364 | $8.38 | $10,063,274 | 1,100,378 | — | plan? amended |
| Dec 4, 2015 PForm 4 → | Dec 8, 6:35 pm EST | ALIMERA SCIENCES INCALIM | 272,249 | $3.01 | $819,578 | 728,718 | +59.6% | plan? |
| Dec 1, 2015 PForm 4 → | Dec 3, 6:14 pm EST | ALIMERA SCIENCES INCALIM | 243,252 | $3.00 | $729,477 | 592,593 | +69.6% | plan? |
| Nov 6, 2015 PForm 4 → | Nov 10, 4:12 pm EST | ALIMERA SCIENCES INCALIM | 73,250 | $2.98 | $218,483 | 470,967 | +18.4% | plan? |
| Oct 30, 2015 PForm 4 → | Nov 3, 5:22 pm EST | ALIMERA SCIENCES INCALIM | 16,542 | $3.00 | $49,626 | 434,342 | +3.96% | plan? |
| Oct 27, 2015 PForm 4 → | Oct 29, 6:05 pm EDT | ALIMERA SCIENCES INCALIM | 59,342 | $3.00 | $177,763 | 426,071 | +16.2% | plan? |
| Oct 22, 2015 PForm 4 → | Oct 26, 5:48 pm EDT | ALIMERA SCIENCES INCALIM | 60,364 | $3.00 | $181,113 | 396,400 | +18.0% | plan? |
| Oct 19, 2015 PForm 4 → | Oct 21, 6:55 pm EDT | ALIMERA SCIENCES INCALIM | 390,040 | $2.97 | $1,159,854 | 366,218 | — | plan? |
| Oct 14, 2015 PForm 4 → | Oct 14, 12:34 pm EDT | CytomX Therapeutics, Inc.CTMX | 625,000 | $12.00 | $7,500,000 | 275,000 | — | plan? |
| Oct 14, 2015 CForm 4 → | Oct 14, 12:34 pm EDT | CytomX Therapeutics, Inc.CTMX | 321,024 | — | — | 160,512 | — | plan? |
| Oct 7, 2015 PForm 4 → | Oct 9, 9:39 pm EDT | ALIMERA SCIENCES INCALIM | 321,785 | $2.42 | $779,951 | 171,198 | — | plan? |
| Sep 28, 2015 SForm 4 → | Sep 30, 6:45 pm EDT | ANTARES PHARMA, INC.ATRS | 1,828,529 | $1.79 | $3,281,995 | 5,348,776 | −25.5% | plan? |
| Sep 22, 2015 PForm 4 → | Sep 22, 10:48 am EDT | REGENXBIO Inc.RGNX | 175,000 | $22.00 | $3,850,000 | 49,000 | — | plan? |
| Sep 22, 2015 CForm 4 → | Sep 22, 10:48 am EDT | REGENXBIO Inc.RGNX | 1,169,042 | — | — | 1,169,042 | — | plan? |
| Sep 18, 2015 SForm 4 → | Sep 22, 1:05 pm EDT | AxoGen, Inc.AXGN | 345,000 | $5.50 | $1,897,983 | 3,381,439 | −9.26% | plan? |
| Sep 3, 2015 PForm 4 → | Feb 19, 2016, 12:38 pm EST | AveXis, Inc.AVXS | 750,317 | $19.47 | $14,605,331 | 112,000 | — | plan? late |
| Jul 28, 2015 PForm 4 → | Jul 28, 11:55 am EDT | Neos Therapeutics, Inc.NEOS | 400,000 | $15.00 | $6,000,000 | 429,166 | +1,371% | plan? |
| Jul 28, 2015 SForm 4 → | Jul 28, 11:55 am EDT | Neos Therapeutics, Inc.NEOS | 166,666 | $15.00 | $2,499,990 | 229,166 | −42.1% | plan? |
| Jul 28, 2015 CXForm 4 → | Jul 28, 11:55 am EDT | Neos Therapeutics, Inc.NEOS | 624,998 | $12.00 | $2,499,984 | 312,499 | — | plan? |
| Jul 17, 2015 SForm 4 → | Jul 21, 5:36 pm EDT | ANTARES PHARMA, INC.ATRS | 231,793 | $2.17 | $503,414 | 6,111,957 | −3.65% | plan? |
| Jul 6, 2015 SForm 4 → | Jul 8, 5:28 pm EDT | ANTARES PHARMA, INC.ATRS | 834,505 | $2.08 | $1,733,354 | 6,213,945 | −11.8% | plan? amended |
| Jun 29, 2015 SForm 4 → | Jul 1, 6:01 pm EDT | ANTARES PHARMA, INC.ATRS | 713,222 | $2.09 | $1,491,582 | 6,581,127 | −9.78% | plan? |
| Jun 26, 2015 SForm 4/A → | Jul 1, 5:54 pm EDT | ANTARES PHARMA, INC.ATRS | 354,534 | $2.24 | $795,197 | 6,840,669 | −4.93% | plan? |
| Jun 24, 2015 SForm 4 → | Jun 26, 5:05 pm EDT | ANTARES PHARMA, INC.ATRS | 756,852 | $2.27 | $1,715,004 | 6,853,826 | −9.94% | plan? amended |
| Jun 23, 2015 PForm 4 → | Jun 25, 3:14 pm EDT | Nivalis Therapeutics, Inc.NVLS | 250,000 | $14.00 | $3,500,000 | 832,216 | +42.9% | plan? |
| Jun 23, 2015 CForm 4 → | Jun 25, 3:14 pm EDT | Nivalis Therapeutics, Inc.NVLS | 3,078,394 | — | — | 754,677 | — | plan? |
| Jun 19, 2015 SForm 4 → | Jun 23, 5:12 pm EDT | ANTARES PHARMA, INC.ATRS | 499,895 | $2.39 | $1,192,395 | 7,134,637 | −6.55% | plan? |
| Jun 16, 2015 SForm 4 → | Jun 18, 5:48 pm EDT | ANTARES PHARMA, INC.ATRS | 478,366 | $2.44 | $1,164,894 | 7,320,109 | −6.13% | plan? |
| Jun 11, 2015 SForm 4 → | Jun 15, 8:20 pm EDT | ANTARES PHARMA, INC.ATRS | 748,030 | $2.44 | $1,825,829 | 3,790,301 | −16.5% | plan? |
| May 12, 2015 PForm 4 → | May 13, 1:00 pm EDT | aTYR PHARMA INCLIFE | 50,000 | $14.00 | $700,000 | 255,764 | +24.3% | plan? |
| May 12, 2015 CForm 4 → | May 13, 1:00 pm EDT | aTYR PHARMA INCLIFE | 461,528 | — | — | 230,764 | — | plan? |
| May 5, 2015 UForm 4 → | May 7, 1:38 pm EDT | Auspex Pharmaceuticals, Inc.ASPX | 4,449,103 | — | — | 0 | — | plan? |
| Apr 8, 2015 SForm 4 → | Apr 9, 1:55 pm EDT | AxoGen, Inc.AXGN | 144,385 | $3.25 | $469,251 | 3,726,439 | −3.73% | plan? |
| Mar 25, 2015 PForm 4 → | Mar 25, 5:19 pm EDT | SteadyMed Ltd.STDY | 737,555 | $8.50 | $6,269,218 | 823,529 | +858% | plan? |
| Mar 25, 2015 CForm 4 → | Mar 25, 5:19 pm EDT | SteadyMed Ltd.STDY | 530,178 | — | — | 265,089 | — | plan? |
| Mar 6, 2015 PForm 4 → | Mar 9, 3:21 pm EDT | eHealth, Inc.EHTH | 30,103 | $9.52 | $286,581 | 1,342,573 | +2.29% | plan? |
| Feb 18, 2015 PForm 4 → | Feb 19, 7:13 pm EST | Invitae CorpNVTA | 175,000 | $16.00 | $2,800,000 | 48,388 | — | plan? |
| Feb 18, 2015 CForm 4 → | Feb 19, 7:13 pm EST | Invitae CorpNVTA | 166,666 | — | — | 166,666 | — | plan? |